category
Nature Biotechnology
date
Mar 5, 2026
slug
status
Published
summary
提出基于基因编辑结果特征而非技术手段的监管框架,主张以科学风险评估替代现有SDN分类体系,适应新型编辑技术的商业化需求并应对气候变化挑战。
tags
基因编辑
核酸蛋白工具酶
type
Post

📄 原文题目

Re-evaluating the site-directed nuclease classification as a regulatory trigger for genome-edited plant products

🔗 原文链接

💡 AI 核心解读

提出基于基因编辑结果特征而非技术手段的监管框架,主张以科学风险评估替代现有SDN分类体系,适应新型编辑技术的商业化需求并应对气候变化挑战。

📝 英文原版摘要

<p>Nature Biotechnology, Published online: 05 March 2026; <a href="https://www.nature.com/articles/s41587-026-03028-0">doi:10.1038/s41587-026-03028-0</a></p>Site-directed nuclease (SDN) classification into SDN-1, SDN-2 and SDN-3 outcomes is used for regulating genome-edited plant products in some countries. This reductive categorization system fails to cover the breadth of genome editing technologies developed over the past decade and their rapidly approaching commercial use. Here, we argue that, in the context of plant breeding, regulations should focus on the characteristics of the genome editing outcome, rather than specific methods used in the development process. Such a science-based, outcome-focused regulatory approach would future-proof the risk-proportionate oversight of plant breeding innovations and enable a more efficient delivery of improved crop varieties amidst growing concerns of climate change and evolving pests and diseases.
致癌性CCDC6-RET融合蛋白是一种双重ATP和ADP依赖的激酶双链RNA结合蛋白DGCR8调控逆转座子驱动的干扰素反应激活
Loading...